June 24, 2026 European Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First PD-1 Inhibitor Plus Antibody-Drug Conjugate Regimen for Adults With Cisplatin-Ineligible Resectable Muscle-Invasive Bladder Cancer
June 24, 2026 WTOP News Names Eagle Hill Consulting A Winner Of The Greater Washington Area Top Workplaces 2026 Award
June 24, 2026 FROM STATESIDE TO SILVERSTONE: JIM BEAM® AND THE CADILLAC FORMULA 1® TEAM TOAST TO AMERICA’S 250TH AT THE BRITISH GRAND PRIX
